Engineers Gate Manager LP Exelixis, Inc. Transaction History

Engineers Gate Manager LP

$5.42 Billion
Q4 2024

A detailed history of Engineers Gate Manager LP transactions in Exelixis, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 92,703 shares of EXEL stock, worth $3.49 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

92,703

Previous 103,652 10.56%

Holding current value

$3.49 Million

Previous $2.69 Million 14.8%

% of portfolio

0.06%

Previous 0.06%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$25.39 - $36.46 $277,995 - $399,200	-10,949 Reduced 10.56%	92,703 $3.09 Million
Q3 2024 Nov 14, 2024	BUY	$21.96 - $27.6 $359,770 - $452,170	16,383 Added 18.77%	103,652 $2.69 Million
Q2 2024 Aug 14, 2024	BUY	$20.34 - $23.73 $496,255 - $578,964	24,398 Added 38.81%	87,269 $1.96 Million
Q1 2024 May 15, 2024	BUY	$20.17 - $23.93 $170,839 - $202,687	8,470 Added 15.57%	62,871 $1.49 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $1.44 Million - $1.8 Million	-74,803 Reduced 57.9%	54,401 $1.31 Million
Q3 2023 Nov 14, 2023	BUY	$19.04 - $22.74 $92,439 - $110,402	4,855 Added 3.9%	129,204 $2.82 Million
Q2 2023 Aug 14, 2023	BUY	$18.17 - $20.48 $1.23 Million - $1.39 Million	67,813 Added 119.95%	124,349 $2.38 Million
Q1 2023 May 15, 2023	SELL	$16.3 - $19.41 $78,924 - $93,983	-4,842 Reduced 7.89%	56,536 $1.1 Million
Q4 2022 Feb 14, 2023	SELL	$14.96 - $17.39 $1.59 Million - $1.85 Million	-106,348 Reduced 63.41%	61,378 $984,000
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $1.95 Million - $2.78 Million	124,649 Added 289.36%	167,726 $2.63 Million
Q2 2022 Aug 15, 2022	BUY	$17.44 - $23.16 $423,652 - $562,602	24,292 Added 129.32%	43,077 $897,000
Q1 2022 May 16, 2022	SELL	$17.03 - $22.67 $150,664 - $200,561	-8,847 Reduced 32.02%	18,785 $426,000
Q4 2021 Feb 14, 2022	SELL	$15.84 - $21.88 $498,152 - $688,104	-31,449 Reduced 53.23%	27,632 $505,000
Q3 2021 Nov 15, 2021	SELL	$16.3 - $21.14 $697,102 - $904,094	-42,767 Reduced 41.99%	59,081 $1.25 Million
Q2 2021 Aug 16, 2021	BUY	$17.95 - $25.56 $678,474 - $966,116	37,798 Added 59.01%	101,848 $1.86 Million
Q1 2021 May 17, 2021	BUY	$20.53 - $25.22 $255,105 - $313,383	12,426 Added 24.07%	64,050 $1.45 Million
Q4 2020 Feb 16, 2021	BUY	$18.39 - $24.8 $711,030 - $958,867	38,664 Added 298.33%	51,624 $1.04 Million
Q3 2020 Nov 16, 2020	SELL	$20.67 - $26.94 $763,343 - $994,894	-36,930 Reduced 74.02%	12,960 $317,000
Q2 2020 Aug 17, 2020	BUY	$16.46 - $27.42 $112,043 - $186,647	6,807 Added 15.8%	49,890 $1.18 Million
Q1 2020 May 15, 2020	BUY	$14.46 - $21.8 $288,086 - $434,321	19,923 Added 86.02%	43,083 $742,000
Q4 2019 Feb 14, 2020	BUY	$15.15 - $18.89 $350,874 - $437,492	23,160 New	23,160 $408,000
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $1.63 Million - $2.09 Million	-92,201 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.93 - $24.75 $791,292 - $1.03 Million	41,801 Added 82.94%	92,201 $1.97 Million
Q1 2019 May 15, 2019	BUY	$19.6 - $24.76 $987,840 - $1.25 Million	50,400 New	50,400 $1.2 Million

Others Institutions Holding EXEL

# of Institutions

565

Shares Held

251M

Call Options Held

1.45M

Put Options Held

1.13M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $12.1B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Exelixis, Inc. Transaction History